Singapore markets closed

Straits Times Index
3,348.87
+12.28(+0.37%)
S&P 500
5,282.22
+4.71(+0.09%)
Dow
38,568.72
-117.60(-0.30%)
Nasdaq
16,829.00
+93.98(+0.56%)
Bitcoin USD
69,226.36
+990.73(+1.45%)
CMC Crypto 200
1,498.41
+30.48(+2.08%)

BMY Jun 2024 39.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.1100

-0.1500

(-57.69%)

As of 10:08AM EDT. Market open.

Loading interactive chart…

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....